Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subclinical-dose esketamine for post-cesarean depression and pain
ChiCTR2400080884Phase 4Not yet recruiting
- Sponsor
- Yongchuan Hospital Affiliated to Chongqing Medical University
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postpartum depression (PPD) and postoperative pain (2 arms), sponsored by Yongchuan Hospital Affiliated to Chongqing Medical University. Primary endpoints: Postnatal depression and Postoperative pain. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2400080884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080884.